查看購物車
  • Simplified Chinese
  • English
封面
市場調查報告書
商品編碼
1873993

生物膜治療市場

Biofilms Treatment Market
出版日期: | 出版商: The Insight Partners | 英文 150 Pages | 商品交期: 1-5個工作天內

價格
簡介目錄

2024年，生物膜治療市場價值約為22.9億美元，預計到2031年將成長至38.8億美元。該市場預計在2031年至2032年間將經歷8.0%的年複合成長率（CAGR）。推動生物膜治療市場發展的關鍵趨勢包括產品發布、核准和技術進步等策略性舉措。

生物膜治療市場分析

傷口和感染的日益增多，以及醫療器材上生物膜的不斷增殖，推動了對生物膜治療的需求，從而促進了全球市場成長。此外，生物膜的日益普遍預計將在預測期內進一步推動市場擴張。研究表明，60%至100%的慢性傷口樣本中都存在生物膜，凸顯了生物膜在慢性傷口中快速且廣泛的存在，因此亟需有效的治療方案。技術進步、創新產品的推出以及新市場參與者的湧入現有望促進全球市場成長。然而，生物膜相關感染的增加、抗生素抗藥性、高昂的成本以及先進傷口護理產品普及率有限等挑戰可能會阻礙市場的整體發展。

生物膜治療市場概覽

醫療保健支出不斷成長、人口老化導致慢性傷口易感性增加、新產品上市以及有利的報銷政策等因素正在推動市場成長。監管機構日益重視生物膜相關感染的公共衛生影響，並制定了旨在預防和治療此類感染的嚴格法規和指南，這反過來又促進了對符合規範的生物膜治療方案的需求。各公司正積極尋求技術創新，以期在傳統方法的基礎上提升生物膜治療效果。這些創新可能包括：研發具有增強抗菌性能的先進傷口敷料；將智慧材料應用於生物膜的檢測和管理；以及開發靶向藥物遞送系統以對抗生物膜內的細菌。此外，研究人員正在利用包括生物技術和奈米技術在內的新技術，開發更有效、更有效率的生物膜治療方案。

戰略洞察

生物膜治療市場促進因素與機遇

慢性傷口、手術傷口和創傷性傷口發生率的增加將有利於市場發展

根據國際糖尿病聯盟的研究，2024年全球糖尿病盛行率約為9.3%，影響約4.63億人，預計2030年將上升至10.2%（約5.78億人）。生物膜對囊性纖維化（CF）患者的肺部和消化系統也有顯著影響，全球有超過7萬人受其影響，其中約3萬人在美國。 CF肺部的生物膜對抗生素治療具有顯著的抗藥性，這加劇了CF帶來的巨大經濟負擔，估計每年高達75.09億美元。此外，醫療技術的進步導致外科手術數量增加，美國每年約進行2,700萬例手術，其中約5%會導致手術部位感染。

新興經濟體研究的不斷成長—為生物膜治療市場成長帶來機會

各領域對微生物生物膜作用的認知不斷提高，為轉化研究中創新技術的開發帶來了新的機遇，旨在減輕其不利影響並發揮其益處。目前的研究重點是開發可與抗生素合併使用的新型化合物以對抗感染。創新策略對於預防和消除具有臨床意義的感染至關重要，尤其是在奈米尺度上。了解生物膜促進感染和抗生素抗藥性的機制，對於開發治療醫院獲得性病原體感染的有效方法至關重要。能夠同時進行診斷和治療的先進多功能奈米材料的合成在當代研究中日益受到關注。轉錄組學、代謝組學和基於轉座子的下一代定序技術的進步，有望發現生物膜研究的新基因標靶。

此外，迫切需要發現能夠針對生物膜特定成分的新型抗生物膜藥物。基於奈米顆粒的抗生物膜藥物研究正成為一個極具前景的領域，尤其是在聯合使用多種藥物的情況下。 2021年4月，密西根州立大學（MSU）獲得了默多克信託基金提供的51.3萬美元資助，從而增強了其生物膜研究能力。因此，正在進行的研究有望對生物膜治療產生積極影響，並為市場成長創造有利可圖的機會。

生物膜治療市場報告細分分析

生物膜治療市場分析按產品、傷口類型和最終用戶進行細分。

  • 依產品分類，市場可分為清創設備、紗布和敷料、植皮和基質等產品。紗布和敷料細分市場在2023年佔據最大的市場佔有率，預計在預測期內將保持最高的複合年成長率。
  • 依傷口類型分類，市場可分為創傷和手術傷口、糖尿病足潰瘍、壓瘡、靜脈性腿部潰瘍和其他傷口。創傷和手術傷口細分市場在2023年佔據最大市場佔有率，預計在2023年至2031年期間將保持最高的複合年成長率。
  • 從終端用戶角度來看，市場可細分為醫院、家庭護理機構和其他終端用戶。醫院細分市場在2023年佔據了最大的市場佔有率，預計在預測期內將保持最高的複合年成長率。

生物膜治療市場佔有率按地域分類分析

生物膜治療市場的地理分析分為五個區域：北美、亞太、歐洲、中東和非洲以及南美/南美和中美洲。

北美在生物膜治療市場佔據領先地位，這主要得益於糖尿病盛行率的上升以及眾多提供傷口護理解決方案的機構的存在。北美生物技術產業在推進生物膜治療方面發揮著至關重要的作用。與全球平均值相比，美國糖尿病（DM）的盛行率已達到流行病等級。隨著糖尿病患者數量的增加，相關併發症也隨之增加。許多機構和出版物都制定了治療和閉合糖尿病足潰瘍（DFU）的建議做法。然而，儘管有這些指南，美國祇有50%的DFU能在一年內癒合。加拿大傷口協會（Wounds Canada，前身為加拿大傷口護理協會）是一家致力於推動加拿大傷口預防和管理的非營利組織，其工作重點包括教育、研究、宣傳和合作。墨西哥傷口護理與癒合協會是一個非營利組織，由一群致力於研究墨西哥傷口和造口的多學科專家組成，旨在促進全面的護理和治療，以提高患者的生活品質。預計未來幾年亞太地區的複合年成長率將最高。

生物膜治療市場報告範圍

生物膜治療市場新聞及最新進展

生物膜治療市場評估是基於從一手和二手研究中收集的定性和定量資料，包括重要的企業出版物、協會資料和資料庫。生物膜治療市場的最新發展包括：

  • 囊性纖維化基金會向 Clarametyx Biosciences 公司投資高達 500 萬美元，用於開發 CMTX-101 藥物。 CMTX-101 是一種旨在治療難治性細菌感染的藥物，例如慢性綠膿桿菌感染，而綠膿桿菌是囊性纖維化患者肺部感染的主要原因之一。 （囊性纖維化基金會，新聞，2024 年）
  • 專注於發現和開發天然人源單株抗體的生物技術公司Trellis Bioscience Inc.宣布，其主要候選抗體TRL1068已獲得美國食品藥物管理局（FDA）的快速通道和合格傳染病產品（QIDP）資格認定。 （資料來源：Trellis Bioscience, Inc.，新聞稿，2024）
  • ASEP醫療控股公司宣布，已利用人工智慧（AI）開發出針對常見生物膜感染的新型改良療法以及用於快速診斷敗血症的方法。 （資料來源：ASEP醫療控股公司，新聞稿，2024年）
  • Medline 和 OMNIA Partners 宣佈建立新的採購合作夥伴關係，旨在為包括州、縣和地方政府、中小學和高等教育系統以及公共安全服務機構在內的公共部門機構提供醫療外科產品組合方面的成本節約方案，使其能夠獲得 Medline 超過 30 萬種醫療用品的豐富產品組合。 （Medline Industries, LP，新聞稿，2022 年）

生物膜治療市場報告涵蓋範圍及成果

題為《生物膜治療市場規模及預測（2021-2031）》的報告對市場進行了全面分析，涵蓋以下領域：

  • 涵蓋範圍內所有關鍵細分市場的全球、區域和國家層面的市場規模和預測
  • 市場動態，例如促進因素、限制因素和關鍵機會
  • 未來主要趨勢
  • 詳細的PEST/波特五力模型與SWOT分析
  • 全球及區域市場分析，重點在於關鍵市場趨勢、主要參與者、法規及最新發展。
  • 產業格局和競爭分析，包括市場集中度、熱力圖分析、主要參與者和最新發展動態
  • 公司詳細概況

目錄

第1章：引言

第2章：生物膜治療市場及主要結論

第3章：研究方法

  • 覆蓋範圍
  • 二手研究
  • 初步研究

第4章：全球生物膜治療及市場概況

  • 概述
  • PEST分析
    • 北美和PEST分析
    • 歐洲和PEST分析
    • 亞太地區及PEST分析
    • 中東和非洲以及 PEST 分析
    • 南美洲和中美洲以及 PEST 分析
  • 專家意見

第5章：生物膜治療市場及主要市場動態

  • 市場促進因素
    • 慢性傷口、手術傷口和創傷性傷口的發生率不斷上升
    • 燒傷病例數不斷增加
  • 市場限制
    • 傷口治療費用高昂
  • 市場機遇
    • 新興經濟體對生物膜治療的研究日益增多
  • 未來趨勢
    • 新技術的開發
  • 影響分析

第6章：生物膜治療市場及全球分析

  • 全球生物膜治療市場收入預測與分析
  • 全球生物膜治療市場（依地域分類）－預測與分析
  • 關鍵參與者的市場定位

第7章：生物膜治療市場分析及產品分類

  • 概述
  • 生物膜治療市場收入佔有率（按產品分類，2024 年和 2031 年）
  • 清創裝置
  • 紗布和敷料
  • 移植和基質
  • 其他產品

第8章：生物膜治療市場分析及依傷口類型分類

  • 概述
  • 生物膜治療市場收入佔有率（按應用領域分類，2024 年和 2031 年）
  • 創傷與手術傷口
  • 糖尿病足潰瘍
  • 壓瘡
  • 靜脈性腿部潰瘍
  • 其他傷口

第9章：生物膜治療市場分析及最終用戶細分

  • 概述
  • 2024 年和 2031 年生物膜治療市場佔有率（按最終用戶分類，%）
  • 醫院
  • 家庭護理機構
  • 其他最終用戶

第10章：生物膜治療市場及地理分析

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非
  • 南美洲和中美洲
    • 巴西
    • 阿根廷

第11章：新冠疫情對全球生物膜治療市場的影響

  • 北美洲
  • 歐洲
  • 亞太
  • 世界其他地區

第12章：生物膜治療市場及產業概況

  • 概述
  • 市場中各公司採取的成長策略（%）
  • 有機發展
    • 概述
  • 無機物發展
    • 概述

第13章：公司簡介

  • Smith and Nephew

第14章：附錄

簡介目錄
Product Code: TIPRE00015873

In 2024, the biofilms treatment market was valued at approximately US$ 2.29 billion and is anticipated to grow to US$ 3.88 billion by 2031. The market is projected to experience a compound annual growth rate (CAGR) of 8.0% from 2031 to 2031. Key trends driving the biofilms treatment market include strategic initiatives such as product launches, approvals, and advancements in technology.

Biofilms Treatment Market Analysis

The rising occurrence of wounds and infections, along with the proliferation of biofilms on medical devices, is driving the demand for biofilm treatments, thereby enhancing market growth globally. Additionally, the increasing prevalence of biofilms is expected to further propel market expansion during the forecast period. Research indicates that biofilms are found in 60 to 100% of chronic wound samples, highlighting their rapid and widespread presence in chronic wounds, which necessitates effective treatment solutions. Technological advancements, the introduction of innovative products, and the emergence of new market players are likely to contribute to global market growth. However, challenges such as the rise of biofilm-related infections, antibiotic resistance, high costs, and limited adoption of advanced wound care products may hinder overall market progress.

Biofilms Treatment Market Overview

Factors such as increasing healthcare spending, an aging population susceptible to chronic wounds, new product introductions, and favorable reimbursement policies are driving market growth. Regulatory bodies are becoming more aware of the public health implications of biofilm-related infections, leading to the establishment of stringent regulations and guidelines aimed at preventing and treating these infections, which in turn boosts the demand for compliant biofilm treatment options. Companies are actively pursuing technological innovations to enhance biofilm treatment beyond conventional methods. These innovations may involve the creation of advanced wound dressings with enhanced antimicrobial properties, the incorporation of smart materials for biofilm detection and management, and the development of targeted drug delivery systems to address bacteria within biofilms. Furthermore, research is ongoing to leverage new technologies, including biotechnology and nanotechnology, to create more effective and efficient biofilm treatment solutions.

Strategic Insights

Biofilms Treatment Market Drivers and Opportunities

Increasing Incidence of Chronic, Surgical, and Traumatic Wounds to Favor Market

According to a study by the International Diabetes Federation, the global prevalence of diabetes was approximately 9.3% in 2024, affecting around 463 million individuals, and is projected to rise to 10.2% (about 578 million) by 2030. Biofilms also have a significant impact on the lungs and digestive systems of cystic fibrosis (CF) patients, with over 70,000 individuals affected worldwide, including around 30,000 in the US. The biofilms present in CF lungs are notably resistant to antibiotic treatment, contributing to the substantial economic burden of CF, estimated at US$ 7,509 million annually. Additionally, advancements in medical technology have led to an increase in surgical procedures, with approximately 27 million surgeries performed annually in the US, of which about 5% result in surgical site infections.

Growing Research in Emerging Economies - An Opportunity for Biofilms Treatment Market Growth

Heightened awareness of the role of microbial biofilms across various sectors is unveiling new opportunities for the development of innovative technologies in translational research aimed at mitigating their adverse effects while harnessing their benefits. Current research is focused on creating novel compounds that can be used alongside antibiotics to combat infections. Innovative strategies are essential for preventing and eliminating clinically significant infections, particularly at the nanoscale. Understanding the mechanisms by which biofilms facilitate infection and antibiotic resistance is crucial for developing effective treatment methods for infections caused by hospital-acquired pathogens. The synthesis of advanced multifunctional nanomaterials that enable simultaneous diagnosis and therapy is gaining traction in contemporary research. Progress in transcriptomics, metabolomics, and transposon-based next-generation sequencing may uncover new genetic targets for biofilm research.

Moreover, there is a pressing need to discover new antibiofilm agents that target specific components of biofilms. Research into nanoparticle-based antibiofilm agents is emerging as a promising field, particularly when multiple agents are utilized. In April 2021, MSU enhanced its biofilm research capabilities with a US$ 513,000 grant from the Murdock Trust. Consequently, ongoing studies and research are expected to positively influence biofilm treatment, creating lucrative opportunities for market growth.

Biofilms Treatment Market Report Segmentation Analysis

The biofilms treatment market analysis is segmented by product, wound type, and end user.

  • By product, the market is categorized into debridement equipment, gauzes and dressings, grafts and matrices, and others. The gauzes and dressings segment accounted for the largest market share in 2023 and is expected to exhibit the highest CAGR during the forecast period.
  • By wound type, the market is divided into traumatic and surgical wounds, diabetic foot ulcers, pressure ulcers, venous leg ulcers, and other wounds. The traumatic and surgical wounds segment held the largest market share in 2023 and is projected to register the highest CAGR from 2023 to 2031.
  • In terms of end user, the market is segmented into hospitals, home care settings, and other end users. The hospitals segment captured the largest market share in 2023 and is anticipated to show the highest CAGR during the forecast period.

Biofilms Treatment Market Share Analysis by Geography

The geographic analysis of the biofilms treatment market is divided into five regions: North America, Asia Pacific, Europe, Middle East & Africa, and South America/South & Central America.

North America leads the biofilms treatment market, driven by the rising prevalence of diabetes and the presence of organizations providing wound care solutions. The biotechnology sector in North America plays a crucial role in advancing biofilms treatment. Diabetes Mellitus (DM) is recognized as having an epidemic prevalence in the US compared to global rates. As the number of diabetic patients increases, so do the associated complications. Various organizations and publications have established preferred practices for healing and closing diabetic foot ulcers (DFU). However, despite these guidelines, only 50% of DFUs heal within a year in the US. Wounds Canada, previously known as the Canadian Association of Wound Care, is a non-profit organization dedicated to advancing wound prevention and management in Canada, focusing on education, research, advocacy, and partnerships. The Mexican Association for Wound Care and Healing is a non-profit organization comprising a multidisciplinary group of specialists committed to studying wounds and stomas in Mexico, promoting comprehensive care and access to treatments to enhance patient quality of life. The Asia Pacific region is expected to experience the highest CAGR in the coming years.

Biofilms Treatment Market Report Scope

Biofilms Treatment Market News and Recent Developments

The biofilms treatment market is assessed through qualitative and quantitative data collected from primary and secondary research, including significant corporate publications, association data, and databases. Recent developments in the biofilms treatment market include:

  • The Cystic Fibrosis Foundation invested up to US$5 million in Clarametyx Biosciences to develop CMTX-101, a drug aimed at addressing difficult-to-treat bacteria such as chronic Pseudomonas aeruginosa, a leading cause of lung infections in cystic fibrosis patients. (Cystic Fibrosis Foundation, News, 2024)
  • Trellis Bioscience Inc., a biotechnology company focused on discovering and developing native human monoclonal antibodies, announced that its lead antibody candidate, TRL1068, received Fast Track and QIDP designations from the US Food and Drug Administration (FDA). (Source: Trellis Bioscience, Inc., News, 2024)
  • Asep Medical Holdings Inc. reported the use of artificial intelligence (AI) to develop new and improved treatments for common biofilm infections and rapid diagnostics for sepsis. (Source: ASEP Medical Holdings Inc., News, 2024)
  • Medline and OMNIA Partners announced a new purchasing partnership, providing cost savings on medical-surgical product portfolios to public sector agencies, including state, county, and local governments, as well as primary and higher education systems and public safety services, allowing access to Medline's extensive portfolio of over 300,000 medical supplies. (Medline Industries, LP, Press Release, 2022)

Biofilms Treatment Market Report Coverage and Deliverables

The report titled "Biofilms Treatment Market Size and Forecast (2021-2031)" offers a comprehensive analysis of the market, covering the following areas:

  • Market size and forecast at global, regional, and country levels for all key market segments included in the scope
  • Market dynamics such as drivers, restraints, and key opportunities
  • Key future trends
  • Detailed PEST/Porter's Five Forces and SWOT analysis
  • Global and regional market analysis highlighting key market trends, major players, regulations, and recent developments
  • Industry landscape and competition analysis, including market concentration, heat map analysis, prominent players, and recent developments
  • Detailed company profiles

Table Of Contents

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 Global Biofilms Treatment Market and By Product
    • 1.3.2 Global Biofilms Treatment Market and By Wound Type
    • 1.3.3 Global Biofilms Treatment Market and By End User
    • 1.3.4 Global Biofilms Treatment market and By Geography

2. Biofilms Treatment Market and Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Global Biofilms Treatment and Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 North America and PEST Analysis
    • 4.2.2 Europe and PEST Analysis
    • 4.2.3 APAC and PEST Analysis
    • 4.2.4 Middle East and Africa and PEST Analysis
    • 4.2.5 South and Central America and PEST Analysis
  • 4.3 Expert Opinions

5. Biofilms Treatment Market and Key Market Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Rising Incidence of Chronic, Surgical, and Traumatic Wounds
    • 5.1.2 Increasing Number of Burn Injuries
  • 5.2 Market Restraints
    • 5.2.1 High Cost of Treating Wounds
  • 5.3 Market Opportunities
    • 5.3.1 Increasing Research on Biofilm Treatment in Emerging Economies
  • 5.4 Future Trends
    • 5.4.1 Development of Novel Technologies
  • 5.5 Impact analysis

6. Biofilms Treatment Market and Global Analysis

  • 6.1 Global Biofilms Treatment Market Revenue Forecast And Analysis
  • 6.2 Global Biofilms Treatment Market, By Geography - Forecast And Analysis
  • 6.3 Market Positioning of Key Players

7. Biofilms Treatment Market Analysis and By Product

  • 7.1 Overview
  • 7.2 Biofilms Treatment Market Revenue Share, by Product (2024 and 2031)
  • 7.3 Debridement Equipment
    • 7.3.1 Overview
    • 7.3.2 Debridement Equipment: Biofilms Treatment Market and Revenue and Forecast to 2031 (US$ Million)
  • 7.4 Gauzes and Dressings
    • 7.4.1 Overview
    • 7.4.2 Gauzes and Dressings: Biofilms Treatment Market and Revenue and Forecast to 2031 (US$ Million)
  • 7.5 Grafts and Matrices
    • 7.5.1 Overview
    • 7.5.2 Grafts and Matrices: Biofilms Treatment Market and Revenue and Forecast to 2031 (US$ Million)
  • 7.6 Other Products
    • 7.6.1 Overview
    • 7.6.2 Other Products: Biofilms Treatment Market and Revenue and Forecast to 2031 (US$ Million)

8. Biofilms Treatment Market Analysis and By Wound Type

  • 8.1 Overview
  • 8.2 Biofilms Treatment Market Revenue Share, by Application (2024 and 2031)
  • 8.3 Traumatic and Surgical Wounds
    • 8.3.1 Overview
    • 8.3.2 Traumatic and Surgical Wounds: Biofilms Treatment Market and Revenue and Forecast to 2031 (US$ Million)
  • 8.4 Diabetic Foot Ulcers
    • 8.4.1 Overview
    • 8.4.2 Diabetic Foot Ulcers: Biofilms Treatment Market and Revenue and Forecast to 2031 (US$ Million)
  • 8.5 Pressure Ulcers
    • 8.5.1 Overview
    • 8.5.2 Pressure Ulcers: Biofilms Treatment Market and Revenue and Forecast to 2031 (US$ Million)
  • 8.6 Venous Leg Ulcers
    • 8.6.1 Overview
    • 8.6.2 Venous Leg Ulcers: Biofilms Treatment Market and Revenue and Forecast to 2031 (US$ Million)
  • 8.7 Other Wounds
    • 8.7.1 Overview
    • 8.7.2 Other Wounds: Biofilms Treatment Market and Revenue and Forecast to 2031 (US$ Million)

9. Biofilms Treatment Market Analysis and By End User

  • 9.1 Overview
  • 9.2 Biofilms Treatment Market Share, by End User, 2024 and 2031, (%)
  • 9.3 Hospitals
    • 9.3.1 Overview
    • 9.3.2 Hospitals: Biofilms Treatment Market and Revenue and Forecast to 2031 (US$ Million)
  • 9.4 Home Care Settings
    • 9.4.1 Overview
    • 9.4.2 Home Care Settings: Biofilms Treatment Market and Revenue and Forecast to 2031 (US$ Million)
  • 9.5 Other End Users
    • 9.5.1 Overview
    • 9.5.2 Other End Users: Biofilms Treatment Market and Revenue and Forecast to 2031 (US$ Million)

10. Biofilms Treatment Market and Geographic Analysis

  • 10.1 North America: Biofilms Treatment Market
    • 10.1.1 Overview
    • 10.1.2 North America: Biofilms Treatment Market - Revenue and Forecast to 2031 (USD Million)
    • 10.1.3 North America Biofilms Treatment Market, by Product and Revenue and Forecast to 2031 (USD Million)
    • 10.1.4 North America Biofilms Treatment Market, by Wound Type and Revenue and Forecast to 2031 (USD Million)
    • 10.1.5 North America Biofilms Treatment Market, by End User and Revenue and Forecast to 2031 (USD Million)
    • 10.1.6 North America: Biofilms Treatment Market, by Country, 2024 and 2031 (%)
    • 10.1.7 US: Biofilms Treatment Market and Revenue and Forecast to 2031 (USD Million)
      • 10.1.7.1 US: Biofilms Treatment Market and Revenue and Forecast to 2031 (USD Million)
        • 10.1.7.1.1 US Biofilms Treatment Market, by Product and Revenue and Forecast to 2031 (USD Million)
        • 10.1.7.1.2 US Biofilms Treatment Market, by Wound Type and Revenue and Forecast to 2031 (USD Million)
        • 10.1.7.1.3 US Biofilms Treatment Market, by End User and Revenue and Forecast to 2031 (USD Million)
    • 10.1.8 Canada: Biofilms Treatment Market and Revenue and Forecast to 2031 (USD Million)
      • 10.1.8.1 Canada: Biofilms Treatment Market and Revenue and Forecast to 2031 (USD Million)
        • 10.1.8.1.1 Canada Biofilms Treatment Market, by Product and Revenue and Forecast to 2031 (USD Million)
        • 10.1.8.1.2 Canada Biofilms Treatment Market, by Wound Type and Revenue and Forecast to 2031 (USD Million)
        • 10.1.8.1.3 Canada Biofilms Treatment Market, by End User and Revenue and Forecast to 2031 (USD Million)
    • 10.1.9 Mexico: Biofilms Treatment Market and Revenue and Forecast to 2031 (USD Million)
      • 10.1.9.1 Mexico: Biofilms Treatment Market and Revenue and Forecast to 2031 (USD Million)
        • 10.1.9.1.1 Mexico Biofilms Treatment Market, by Product and Revenue and Forecast to 2031 (USD Million)
        • 10.1.9.1.2 Mexico Biofilms Treatment Market, by Wound Type and Revenue and Forecast to 2031 (USD Million)
        • 10.1.9.1.3 Mexico Biofilms Treatment Market, by End User and Revenue and Forecast to 2031 (USD Million)
  • 10.2 Europe: Biofilms Treatment Market
    • 10.2.1 Overview
    • 10.2.2 Europe: Biofilms Treatment Market - Revenue and Forecast to 2031 (USD Million)
    • 10.2.3 Europe Biofilms Treatment Market, by Product and Revenue and Forecast to 2031 (USD Million)
    • 10.2.4 Europe Biofilms Treatment Market, by Wound Type and Revenue and Forecast to 2031 (USD Million)
    • 10.2.5 Europe Biofilms Treatment Market, by End User and Revenue and Forecast to 2031 (USD Million)
    • 10.2.6 Europe: Biofilms Treatment Market, by Country, 2024 and 2031 (%)
    • 10.2.7 Germany: Biofilms Treatment Market and Revenue and Forecast to 2031 (USD Million)
      • 10.2.7.1 Germany: Biofilms Treatment Market and Revenue and Forecast to 2031 (USD Million)
        • 10.2.7.1.1 Germany Biofilms Treatment Market, by Product and Revenue and Forecast to 2031 (USD Million)
        • 10.2.7.1.2 Germany Biofilms Treatment Market, by Wound Type and Revenue and Forecast to 2031 (USD Million)
        • 10.2.7.1.3 Germany Biofilms Treatment Market, by End User and Revenue and Forecast to 2031 (USD Million)
    • 10.2.8 France: Biofilms Treatment Market and Revenue and Forecast to 2031 (USD Million)
      • 10.2.8.1 France: Biofilms Treatment Market and Revenue and Forecast to 2031 (USD Million)
        • 10.2.8.1.1 France Biofilms Treatment Market, by Product and Revenue and Forecast to 2031 (USD Million)
        • 10.2.8.1.2 France Biofilms Treatment Market, by Wound Type and Revenue and Forecast to 2031 (USD Million)
        • 10.2.8.1.3 France Biofilms Treatment Market, by End User and Revenue and Forecast to 2031 (USD Million)
    • 10.2.9 United Kingdom: Biofilms Treatment Market and Revenue and Forecast to 2031 (USD Million)
      • 10.2.9.1 United Kingdom: Biofilms Treatment Market and Revenue and Forecast to 2031 (USD Million)
        • 10.2.9.1.1 United Kingdom Biofilms Treatment Market, by Product and Revenue and Forecast to 2031 (USD Million)
        • 10.2.9.1.2 United Kingdom Biofilms Treatment Market, by Wound Type and Revenue and Forecast to 2031 (USD Million)
        • 10.2.9.1.3 United Kingdom Biofilms Treatment Market, by End User and Revenue and Forecast to 2031 (USD Million)
    • 10.2.10 Italy: Biofilms Treatment Market and Revenue and Forecast to 2031 (USD Million)
      • 10.2.10.1 Italy: Biofilms Treatment Market and Revenue and Forecast to 2031 (USD Million)
        • 10.2.10.1.1 Italy Biofilms Treatment Market, by Product and Revenue and Forecast to 2031 (USD Million)
        • 10.2.10.1.2 Italy Biofilms Treatment Market, by Wound Type and Revenue and Forecast to 2031 (USD Million)
        • 10.2.10.1.3 Italy Biofilms Treatment Market, by End User and Revenue and Forecast to 2031 (USD Million)
    • 10.2.11 Spain: Biofilms Treatment Market and Revenue and Forecast to 2031 (USD Million)
      • 10.2.11.1 Spain: Biofilms Treatment Market and Revenue and Forecast to 2031 (USD Million)
        • 10.2.11.1.1 Spain Biofilms Treatment Market, by Product and Revenue and Forecast to 2031 (USD Million)
        • 10.2.11.1.2 Spain Biofilms Treatment Market, by Wound Type and Revenue and Forecast to 2031 (USD Million)
        • 10.2.11.1.3 Spain Biofilms Treatment Market, by End User and Revenue and Forecast to 2031 (USD Million)
  • 10.3 Asia Pacific: Biofilms Treatment Market
    • 10.3.1 Overview
    • 10.3.2 Asia Pacific: Biofilms Treatment Market and Revenue and Forecast to 2031 (USD Millions)
    • 10.3.3 Asia Pacific: Biofilms Treatment Market, by Product, 2018-2031 (USD Millions)
    • 10.3.4 Asia Pacific: Biofilms Treatment Market, by Wound Type, 2018-2031 (USD Millions)
    • 10.3.5 Asia Pacific: Biofilms Treatment Market, by End User, 2018-2031 (USD Millions)
    • 10.3.6 Asia Pacific: Biofilms Treatment Market, by Country, 2024 and 2031 (%)
    • 10.3.7 China: Biofilms Treatment Market
      • 10.3.7.1 China: Biofilms Treatment Market and Revenue and Forecast to 2031 (USD Millions)
        • 10.3.7.1.1 China: Biofilms Treatment Market, by Product, 2018-2031 (USD Millions)
        • 10.3.7.1.2 China: Biofilms Treatment Market, by Wound Type, 2018-2031 (USD Millions)
        • 10.3.7.1.3 China: Biofilms Treatment Market, by End User, 2018-2031 (USD Millions)
    • 10.3.8 Japan: Biofilms Treatment Market
      • 10.3.8.1 Japan: Biofilms Treatment Market and Revenue and Forecast to 2031 (USD Millions)
        • 10.3.8.1.1 Japan: Biofilms Treatment Market, by Product, 2018-2031 (USD Millions)
        • 10.3.8.1.2 Japan: Biofilms Treatment Market, by Wound Type, 2018-2031 (USD Millions)
        • 10.3.8.1.3 Japan: Biofilms Treatment Market, by End User, 2018-2031 (USD Millions)
    • 10.3.9 India: Biofilms Treatment Market
      • 10.3.9.1 India: Biofilms Treatment Market and Revenue and Forecast to 2031 (USD Millions)
        • 10.3.9.1.1 India: Biofilms Treatment Market, by Product, 2018-2031 (USD Millions)
        • 10.3.9.1.2 India: Biofilms Treatment Market, by Wound Type, 2018-2031 (USD Millions)
        • 10.3.9.1.3 India: Biofilms Treatment Market, by End User, 2018-2031 (USD Millions)
    • 10.3.10 South Korea: Biofilms Treatment Market
      • 10.3.10.1 South Korea: Biofilms Treatment Market and Revenue and Forecast to 2031 (USD Millions)
        • 10.3.10.1.1 South Korea: Biofilms Treatment Market, by Product, 2018-2031 (USD Millions)
        • 10.3.10.1.2 South Korea: Biofilms Treatment Market, by Wound Type, 2018-2031 (USD Millions)
        • 10.3.10.1.3 South Korea: Biofilms Treatment Market, by End User, 2018-2031 (USD Millions)
    • 10.3.11 Australia: Biofilms Treatment Market
      • 10.3.11.1 Australia: Biofilms Treatment Market and Revenue and Forecast to 2031 (USD Millions)
        • 10.3.11.1.1 Australia: Biofilms Treatment Market, by Product, 2018-2031 (USD Millions)
        • 10.3.11.1.2 Australia: Biofilms Treatment Market, by Wound Type, 2018-2031 (USD Millions)
        • 10.3.11.1.3 Australia: Biofilms Treatment Market, by End User, 2018-2031 (USD Millions)
  • 10.4 Middle East and Africa: Biofilms Treatment Market
    • 10.4.1 Overview
    • 10.4.2 Middle East and Africa: Biofilms Treatment Market- Revenue and Forecast to 2031 (USD Million)
    • 10.4.3 Middle East and Africa Biofilms Treatment Market, by Product and Revenue and Forecast to 2031 (USD Million)
    • 10.4.4 Middle East and Africa Biofilms Treatment Market, by Wound Type and Revenue and Forecast to 2031 (USD Million)
    • 10.4.5 Middle East and Africa Biofilms Treatment Market, by End User and Revenue and Forecast to 2031 (USD Million)
    • 10.4.6 Middle East and Africa: Biofilms Treatment Market, by Country, 2024 and 2031 (%)
    • 10.4.7 Saudi Arabia: Biofilms Treatment Marketand Revenue and Forecast to 2031 (USD Million)
      • 10.4.7.1 Saudi Arabia: Biofilms Treatment Marketand Revenue and Forecast to 2031 (USD Million)
        • 10.4.7.1.1 Saudi Arabia Biofilms Treatment Market, by Product and Revenue and Forecast to 2031 (USD Million)
        • 10.4.7.1.2 Saudi Arabia Biofilms Treatment Market, by Wound Type and Revenue and Forecast to 2031 (USD Million)
        • 10.4.7.1.3 Saudi Arabia Biofilms Treatment Market, by End User and Revenue and Forecast to 2031 (USD Million)
    • 10.4.8 UAE: Biofilms Treatment Marketand Revenue and Forecast to 2031 (USD Million)
      • 10.4.8.1 UAE: Biofilms Treatment Marketand Revenue and Forecast to 2031 (USD Million)
        • 10.4.8.1.1 UAE Biofilms Treatment Market, by Product and Revenue and Forecast to 2031 (USD Million)
        • 10.4.8.1.2 UAE Biofilms Treatment Market, by Wound Type and Revenue and Forecast to 2031 (USD Million)
        • 10.4.8.1.3 UAE Biofilms Treatment Market, by End User and Revenue and Forecast to 2031 (USD Million)
    • 10.4.9 South Africa: Biofilms Treatment Marketand Revenue and Forecast to 2031 (USD Million)
      • 10.4.9.1 South Africa: Biofilms Treatment Marketand Revenue and Forecast to 2031 (USD Million)
        • 10.4.9.1.1 South Africa Biofilms Treatment Market, by Product and Revenue and Forecast to 2031 (USD Million)
        • 10.4.9.1.2 South Africa Biofilms Treatment Market, by Wound Type and Revenue and Forecast to 2031 (USD Million)
      • 10.4.9.2 South Africa Biofilms Treatment Market, by End User and Revenue and Forecast to 2031 (USD Million)
  • 10.6 South and Central America: Biofilms Treatment Market
    • 10.6.1 Overview
    • 10.6.2 South and Central America: Biofilms Treatment Market - Revenue and Forecast to 2031 (USD Million)
    • 10.6.3 South and Central America Biofilms Treatment Market, by Product and Revenue and Forecast to 2031 (USD Million)
    • 10.6.4 South and Central America Biofilms Treatment Market, by Wound Type and Revenue and Forecast to 2031 (USD Million)
    • 10.6.5 South and Central America Biofilms Treatment Market, by End User and Revenue and Forecast to 2031 (USD Million)
    • 10.6.6 South and Central America: Biofilms Treatment Market, by Country, 2024 and 2031 (%)
    • 10.6.7 Brazil: Biofilms Treatment Market and Revenue and Forecast to 2031 (USD Million)
      • 10.6.7.1 Brazil: Biofilms Treatment Market and Revenue and Forecast to 2031 (USD Million)
        • 10.6.7.1.1 Brazil Biofilms Treatment Market, by Product and Revenue and Forecast to 2031 (USD Million)
        • 10.6.7.1.2 Brazil Biofilms Treatment Market, by Wound Type and Revenue and Forecast to 2031 (USD Million)
        • 10.6.7.1.3 Brazil Biofilms Treatment Market, by End User and Revenue and Forecast to 2031 (USD Million)
    • 10.6.8 Argentina: Biofilms Treatment Market and Revenue and Forecast to 2031 (USD Million)
      • 10.6.8.1 Argentina: Biofilms Treatment Market and Revenue and Forecast to 2031 (USD Million)
        • 10.6.8.1.1 Argentina Biofilms Treatment Market, by Product and Revenue and Forecast to 2031 (USD Million)
        • 10.6.8.1.2 Argentina Biofilms Treatment Market, by Wound Type and Revenue and Forecast to 2031 (USD Million)
        • 10.6.8.1.3 Argentina Biofilms Treatment Market, by End User and Revenue and Forecast to 2031 (USD Million)

11. Impact of COVID-19 Pandemic On Global Biofilms Treatment Market

  • 11.1 North America: Impact Assessment of COVID-19 Pandemic
  • 11.2 Europe: Impact Assessment of COVID-19 Pandemic
  • 11.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
  • 11.4 Rest of the World: Impact Assessment of COVID-19 Pandemic

12. Biofilms Treatment MarketandIndustry Landscape

  • 12.1 Overview
  • 12.2 Growth Strategies Done by the Companies in the Market, (%)
  • 12.3 Organic Developments
    • 12.3.1 Overview
  • 12.4 Inorganic Developments
    • 12.4.1 Overview

13. COMPANY PROFILES

  • 13.1 Smith and Nephew

14. Appendix

  • 14.1 About The Insight Partners
  • 14.2 Word Index